Actipulse Neuroscience is a Y Combinator backed neurotechnology company, specialized in neuromodulation medical devices designed to target various neurological and psychiatric conditions. We are based in Mexico City, Paris, and Montreal, with a team of 35 researchers, MDs, and engineers.

The company already has a device on market for the treatment of depression in a clinical setting, as well as numerous indications in different research phases, from preclinical to Phase 3 studies.

As we embark on an exciting new chapter, we are expanding our offerings to include a digital health vertical for our market approved devices, aimed at enhancing the treatment experience for both medical professionals and patients through sophisticated digital health applications, both in a clinical and at home setting.